Cargando…
Pharmacokinetics-based clinical management of acquired von Willebrand syndrome: a case report
von Willebrand disease (VWD) is a common bleeding disorder caused by defective or low levels of von Willebrand factor (VWF). Although most cases of VWD are caused by genetic mutations, some are acquired due to various disease states. In managing VWD, the aim is to normalize plasma levels of both VWF...
Autores principales: | Baldeo, Candice M, Rivera, Candido E, Tun, Han W, Vishnu, Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783106/ https://www.ncbi.nlm.nih.gov/pubmed/29403324 http://dx.doi.org/10.2147/JBM.S152663 |
Ejemplares similares
-
Acquired Von Willebrand's Syndrome in Systemic Lupus Erythematosus
por: Taveras Alam, Sara, et al.
Publicado: (2014) -
Acquired von Willebrand syndrome and lymphoproliferative disorders: A case report
por: Nicol, Christophe, et al.
Publicado: (2020) -
Acquired von Willebrand syndrome: focused for hematologists
por: Franchini, Massimo, et al.
Publicado: (2020) -
New Developments in Diagnosis and Management of Acquired Hemophilia and Acquired von Willebrand Syndrome
por: Leebeek, Frank W. G.
Publicado: (2021) -
Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
por: Poza, María, et al.
Publicado: (2021)